C-reactive protein levels in the first three hours after acute cerebral infarction

International Journal of Neuroscience

Volumn 121, Issue 2, 2011, Pages 65-68

  Camerlingo, Massimo ^a   Valente, Laura ^a   Tognozzi, Marcello ^a   Beretta, Gian Luca ^b   Moschini, Luca ^c   Cesana, Bruno Mario ^d  

^a Policlinico San Marco   (Italy)

^b Clinical Chemistry Laboratory   (Italy)

^c Radiology Department   (Italy)

^d UNIVERSITY OF BRESCIA   (Italy)

Author keywords

Acute phase reactants; C reactive protein; Cerebral infarction; Stroke

Indexed keywords

C REACTIVE PROTEIN;

AGE DISTRIBUTION; AGED; ARTICLE; BRAIN INFARCTION; BRAIN ISCHEMIA; BRAIN VENTRICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HEART DISEASE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; SEX DIFFERENCE; SMOKING;

AGED; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CEREBRAL INFARCTION; FEMALE; HUMANS; MALE; RISK FACTORS; TIME FACTORS;

EID: 78651106205     PISSN: 00207454     EISSN: 15635279     Source Type: Journal    
DOI: 10.3109/00207454.2010.530005     Document Type: Article

References (32)

1. Anuk, T., Assayag, E. B., Rotstein, R., Fusman, R., Zeltser, D., Berliner, S., et al. (2002). Prognostic implications of admission inflammatory profile in acute ischemic neurological events. Acta Neurologica Scandinavica, 106, 196-199.
2. Audebert, H. J., Rott, M. M., Eck, T., & Haberl, R. L. (2004). Systemic inflammatory response depends on initial stroke severity but is attenuated by successful thrombolysis. Stroke, 35, 2128-2133.
3. Bamford, J., Sandercock, P., Dennis, M., Burn, J., & Warlow, C. (1991). Classification and natural history of identifiable subtypes of cerebral infarction. Lancet, 337, 1521-1526.
4. Blake, G. J., & Ridcker, P. M. (2002). Inflammatory bio-markers and cardiovascular risk prediction. Journal of Internal Medicine, 252, 283-294.
5. Canova, C. R., Courtin, C., & Reinhart, W. H. (1999). C-reactive protein (CRP) in cerebro-vascular events. Atherosclerosis, 147, 49-53.
6. Cesana, B. M., & Marubini, E. (1995). Dimensione del campione nella ricerca bio-medica. Milano, Centro "Zambon", Istituto di Statistica Medica e Biometria della facoltá di Medicina e Chirurgia, Universitá degli Studi di Milano p. 107.
7. Chen, H., OReilly, E. J., Schwarzschild, M. A., & Ascherio, A. (2008). Peripheral inflammatory biomarkers and risk of Parkinsons disease. American Journal of Epidemiology, 167, 90-95.
8. Di Napoli, M., Di Gianfilippo, G., Sollecito, A., & Bcola, V. (2000). C-reactive protein and outcome after first-ever ischemic stroke. Stroke, 31, 238-239.
9. Di Napoli, M., Papa, F., & Bocola, V. (2001a). Prognostic influence of increased C-reactive protein and fibrinogen levels in ischemic stroke. Stroke, 32, 133-138
10. Di Napoli, M., Papa, F., & Bocola, V. (2001b). C-reactive protein in ischemic stroke: An independent prognostic factor. Stroke, 32, 917-924.
11. Di Napoli, M., & Papa, F. (2002). Inflammation, hemostatic markers, and antithrombotic agents in relation to long-term risk of new cardiovascular events in first-ever ischemic stroke patients. Stroke, 33, 1763-1771.
12. Di Napoli, M., Schwaninger, M., Cappelli, R., Ceccarelli, E., Di Gianfilippo, G., Donati, C., et al. (2005). Evaluation of Creactive protein measurement for assessing the risk and prognosis in ischemic stroke, A statement for health care professionals from CRP pooling project members. Stroke, 36, 1316-1329.
13. Dinargl, U., Iadecola, C., & Moskowitz, M. A. (1999). Pathobiology of ischaemic stroke: An integrated view. Trends in Neurosciences, 23, 391-397.
14. Eikelboom, J. W., Hankey, G. J., Baker, R. I., McQuillan, A., Thom, J., Staton, J., et al. (2003). C-reactive protein in ischemic stroke and its etiologic subtypes. Journal of Stroke and Cerebrovascular Diseases, 12, 74-81.
15. Elkind, M. S. V., Coates, K., Tai, W., Paik, M. W., Boden-Albala, B., & Sacco, R. L. (2006). Levels of acute phase proteins remain stable after ischemic stroke. BMC Neurology, 6, 37.
16. Emsley, H. C., Smith, C. J., Gavin, C. M., Georgiou, R. F., Vail, A., Barberan, E.M., et al. (2003). An early and sustained peripheral inflammatory response in acute ischaemic stroke: Relationships with infection and atherosclerosis. Journal of Neuroimmunology, 139, 93-101.
17. Giovannoni, G., Miller, D. H., Losseff, N. A., Sailer, M., Lewellyn- Smith, N., Thompson, A. J., et al. (2001). Serum inflammatory markers and clinical/MRI markers of disease progression in multiple sclerosis. Journal of Neurology, 248, 487-495.
18. Idicula, T. T., Brogger, J., Naess, H., Waje-Andreassen, U., & Thomassen, L. (2009). Admission C-reactive protein after acute ischemic stroke is associated with stroke severity and mortality: The Bergen stroke study. BMC Neurology, 9, 18.
19. Ladenvall, C., Jood, K., Bloomstrand, C., Nilsson, S., Jern, C., & Landevall, P. (2006). Serum C-reactive protein concentration and genotype in relation to ischemic stroke subtypes. Stroke, 37, 2017-2023.
20. Masotti, L., Ceccarelli, E., Forconi, S., & Cappelli, R. (2005). Prognostic role of C-reactive protein in very old patients with acute ischaemic stroke. Journal of International Medical Research, 258, 145-152.
21. Modrego, P. J., Boned, B., Berlanga, J. J., & Serrano, M. (2008). Plasmatic B-Type natriuretic peptide and C-reactive protein in hyperacute stroke as markers of CT-evidence of brain edema. International Journal of Medical Sciences, 25, 18-23.
22. Montaner, J., Fernandez-Cadenas, I., Molina, C. A., Ribo, M., Huertas, R., & Rosell, A., et al. (2006). Post-stroke C-reactive protein is a powerful prognostic tool among candidates for thrombolysis. Stroke, 37, 1205-1210.
23. Muir, K. W., Weir, C. J., Alwan, W., Squire, I. B., & Lees, K. R. (1999). C-reactive protein and outcome after ischemic stroke. Stroke, 30, 981-985.
24. National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. (1995). Tissue plasminogen activator for acute ischemic stroke. New England Journal of Medicine, 333, 1581-1587
25. OBryant, S. E., Waring, S. C., Hobson, V., Hall, J. R., Moore, C. B., & Bottiglieri, T. (2010). Decreased C-reactive protein levels in Alzheimer disease. Journal of Geriatric Psychiatry and Neurology, 23, 49-53.
26. Rallidis, L. S., Vikelis, M., Panagiotakos, D. B., Rizos, I., Zolindaki, M. G., Kaliva, K., et al. (2006). Inflammatory markers and inhospital mortality in acute ischaemic stroke. Atherosclerosis, 189, 193-197.
27. Ross, R. (1999). Atherosclerosis: an inflammatory disease. New England Journal of Medicine, 340, 115-126.
28. Rost, N. S.,Wolf, P. A., Kase, C. S., Kelly-Hayes, M., Silbershatz, S., Massaro, J.M., et al. (2001). Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack. Stroke, 32, 2575-2579.
29. Smith, C. J., Emsley, H. C. A., Gavin, C. M., Georgiou, R. F., Vail, A., Barberan, E. M., et al. (2004). Peak plasma interleukin-6 and other peripheral markers of inflammation in the first week of ischaemic stroke correlate with brain. BMC Neurology, 4, 2.
30. Winbeck, K., Poppert, H., Etgen, T., Conrad, B., & Sander, D. (2002). Prognostic relevance of early serial C-reactive protein measurements after first ischemic stroke. Stroke, 33, 2459-2464.
31. Yoldas, T., Gonen, M., Godekmerdam, A., Ilham, F., & Bayram, E. (2007). The serum high-sensitive C-reactive protein and homocysteine levels to evaluate the progress of acute stroke. Mediators Inflammation, 15929
32. Young, B., Gleeson, M., & Cripps, A. W. (1991). C-reactive protein: a critical review. Pathology, 23, 118-124.